vs

Side-by-side financial comparison of American Assets Trust, Inc. (AAT) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.

American Assets Trust, Inc. is the larger business by last-quarter revenue ($110.6M vs $62.1M, roughly 1.8× Cytek Biosciences, Inc.). American Assets Trust, Inc. runs the higher net margin — 6.1% vs -70.9%, a 77.0% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 1.8%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -0.1%).

Personal Assets Trust is a large British investment trust. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The chairman is Iain Ferguson CBE.

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

AAT vs CTKB — Head-to-Head

Bigger by revenue
AAT
AAT
1.8× larger
AAT
$110.6M
$62.1M
CTKB
Growing faster (revenue YoY)
CTKB
CTKB
+6.3% gap
CTKB
8.1%
1.8%
AAT
Higher net margin
AAT
AAT
77.0% more per $
AAT
6.1%
-70.9%
CTKB
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
-0.1%
AAT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AAT
AAT
CTKB
CTKB
Revenue
$110.6M
$62.1M
Net Profit
$6.7M
$-44.1M
Gross Margin
52.9%
Operating Margin
23.4%
-9.0%
Net Margin
6.1%
-70.9%
Revenue YoY
1.8%
8.1%
Net Profit YoY
-16.3%
-557.1%
EPS (diluted)
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAT
AAT
CTKB
CTKB
Q1 26
$110.6M
Q4 25
$110.1M
$62.1M
Q3 25
$109.6M
$52.3M
Q2 25
$107.9M
$45.6M
Q1 25
$108.6M
$41.5M
Q4 24
$113.5M
$57.5M
Q3 24
$122.8M
$51.5M
Q2 24
$110.9M
$46.6M
Net Profit
AAT
AAT
CTKB
CTKB
Q1 26
$6.7M
Q4 25
$-44.1M
Q3 25
$4.5M
$-5.5M
Q2 25
$5.5M
$-5.6M
Q1 25
$42.5M
$-11.4M
Q4 24
$9.6M
Q3 24
$16.7M
$941.0K
Q2 24
$11.9M
$-10.4M
Gross Margin
AAT
AAT
CTKB
CTKB
Q1 26
Q4 25
59.4%
52.9%
Q3 25
60.5%
52.7%
Q2 25
62.6%
52.3%
Q1 25
62.0%
48.6%
Q4 24
61.3%
58.5%
Q3 24
65.5%
56.3%
Q2 24
63.6%
54.6%
Operating Margin
AAT
AAT
CTKB
CTKB
Q1 26
23.4%
Q4 25
21.1%
-9.0%
Q3 25
22.6%
-17.6%
Q2 25
24.1%
-23.3%
Q1 25
66.3%
-36.1%
Q4 24
26.5%
5.2%
Q3 24
30.8%
-8.2%
Q2 24
27.8%
-18.3%
Net Margin
AAT
AAT
CTKB
CTKB
Q1 26
6.1%
Q4 25
-70.9%
Q3 25
4.1%
-10.5%
Q2 25
5.1%
-12.2%
Q1 25
39.2%
-27.5%
Q4 24
16.8%
Q3 24
13.6%
1.8%
Q2 24
10.7%
-22.4%
EPS (diluted)
AAT
AAT
CTKB
CTKB
Q1 26
$0.08
Q4 25
$0.06
Q3 25
$0.07
Q2 25
$0.09
Q1 25
$0.70
Q4 24
$0.14
Q3 24
$0.28
Q2 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAT
AAT
CTKB
CTKB
Cash + ST InvestmentsLiquidity on hand
$118.3M
$90.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$341.7M
Total Assets
$2.9B
$461.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAT
AAT
CTKB
CTKB
Q1 26
$118.3M
Q4 25
$129.4M
$90.9M
Q3 25
$138.7M
$93.3M
Q2 25
$143.7M
$75.5M
Q1 25
$143.9M
$95.3M
Q4 24
$425.7M
$98.7M
Q3 24
$533.0M
$162.3M
Q2 24
$114.9M
$177.9M
Total Debt
AAT
AAT
CTKB
CTKB
Q1 26
Q4 25
$1.7B
Q3 25
Q2 25
Q1 25
Q4 24
$2.0B
Q3 24
Q2 24
Stockholders' Equity
AAT
AAT
CTKB
CTKB
Q1 26
$1.1B
Q4 25
$1.2B
$341.7M
Q3 25
$1.2B
$378.6M
Q2 25
$1.2B
$377.6M
Q1 25
$1.2B
$379.6M
Q4 24
$1.2B
$395.7M
Q3 24
$1.2B
$385.5M
Q2 24
$1.2B
$389.1M
Total Assets
AAT
AAT
CTKB
CTKB
Q1 26
$2.9B
Q4 25
$2.9B
$461.5M
Q3 25
$2.9B
$494.9M
Q2 25
$3.0B
$493.3M
Q1 25
$3.0B
$482.6M
Q4 24
$3.3B
$499.5M
Q3 24
$3.4B
$491.2M
Q2 24
$3.0B
$483.7M
Debt / Equity
AAT
AAT
CTKB
CTKB
Q1 26
Q4 25
1.48×
Q3 25
Q2 25
Q1 25
Q4 24
1.72×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAT
AAT
CTKB
CTKB
Operating Cash FlowLast quarter
$-771.0K
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-2.9%
Capex IntensityCapex / Revenue
14.5%
1.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAT
AAT
CTKB
CTKB
Q1 26
Q4 25
$167.1M
$-771.0K
Q3 25
$40.5M
$-3.9M
Q2 25
$49.2M
$108.0K
Q1 25
$36.9M
$-125.0K
Q4 24
$207.1M
$2.0M
Q3 24
$52.4M
$13.2M
Q2 24
$59.3M
$6.2M
Free Cash Flow
AAT
AAT
CTKB
CTKB
Q1 26
Q4 25
$94.9M
$-1.8M
Q3 25
$23.1M
$-4.6M
Q2 25
$28.4M
$-1.5M
Q1 25
$20.4M
$-974.0K
Q4 24
$136.9M
$1.1M
Q3 24
$28.0M
$12.2M
Q2 24
$43.6M
$5.2M
FCF Margin
AAT
AAT
CTKB
CTKB
Q1 26
Q4 25
86.2%
-2.9%
Q3 25
21.1%
-8.7%
Q2 25
26.3%
-3.2%
Q1 25
18.8%
-2.3%
Q4 24
120.7%
1.9%
Q3 24
22.8%
23.7%
Q2 24
39.3%
11.0%
Capex Intensity
AAT
AAT
CTKB
CTKB
Q1 26
14.5%
Q4 25
65.6%
1.6%
Q3 25
15.9%
1.3%
Q2 25
19.3%
3.5%
Q1 25
15.1%
2.0%
Q4 24
61.9%
1.6%
Q3 24
19.9%
2.0%
Q2 24
14.1%
2.3%
Cash Conversion
AAT
AAT
CTKB
CTKB
Q1 26
Q4 25
Q3 25
8.98×
Q2 25
9.01×
Q1 25
0.87×
Q4 24
0.21×
Q3 24
3.15×
14.05×
Q2 24
4.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AAT
AAT

Rental income$104.4M94%
Other$6.2M6%

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

Related Comparisons